Clinical Trial Update: Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) in JIA [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating transcutaneous cervical vagus nerve stimulation for juvenile idiopathic arthritis has been terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• Transcutaneous cervical vagus nerve stimulation (tcVNS) device

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Juvenile Idiopathic Arthritis (JIA) | Phase 2 | Status: TERMINATED | Results posted: 2025-11-25